Sinopharm Group Co. Ltd Cash Flow-to-Debt Ratio
Sinopharm Group Co. Ltd cash flow-to-debt ratio. Sinopharm Group Co. Ltd (X2S) has a Cash Flow-to-Debt Ratio of -0.01x as of June 2023, meaning its operating cash flow of €-2.63 Billion could theoretically repay 0% of its total liabilities (€304.58 Billion) in one year. Check Sinopharm Group Co. Ltd (X2S) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sinopharm Group Co. Ltd (2013–2025)
Cash flow-to-debt ratio of Sinopharm Group Co. Ltd from 2013 to 2025. Historical debt coverage capacity for Sinopharm Group Co. Ltd across 13 annual periods. Check X2S capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Sinopharm Group Co. Ltd Cash Flow-to-Debt Ratio by Year (2013–2025)
Sinopharm Group Co. Ltd cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Sinopharm Group Co. Ltd. For the full cash flow conversion analysis, see how efficiently does Sinopharm Group Co. Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | €14.14 Billion | €256.20 Billion | ▲ +27.2% |
| 2024 | 0.04x | €11.55 Billion | €266.14 Billion | ▼ -33.5% |
| 2023 | 0.07x | €17.17 Billion | €263.08 Billion | ▼ -20.7% |
| 2022 | 0.08x | €20.96 Billion | €254.71 Billion | ▲ +108.5% |
| 2021 | 0.04x | €9.31 Billion | €235.76 Billion | ▼ -21.7% |
| 2020 | 0.05x | €11.15 Billion | €221.29 Billion | ▼ -48.2% |
| 2019 | 0.10x | €18.78 Billion | €192.95 Billion | ▲ +346.1% |
| 2018 | 0.02x | €3.65 Billion | €167.50 Billion | ▼ -19.6% |
| 2017 | 0.03x | €3.21 Billion | €118.27 Billion | ▼ -66.8% |
| 2016 | 0.08x | €9.26 Billion | €113.18 Billion | ▼ -39.9% |
| 2015 | 0.14x | €13.41 Billion | €98.55 Billion | ▲ +126.1% |
| 2014 | 0.06x | €5.56 Billion | €92.37 Billion | ▼ -6.4% |
| 2013 | 0.06x | €4.94 Billion | €76.84 Billion | — |